Facebook Pixel Driving Research Continuity in Indian R&D through Remote Lab Operations | Bio Spectrum – business – Lesen Sie diese Geschichte auf Magzter.com
Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr

Versuchen GOLD - Frei

Driving Research Continuity in Indian R&D through Remote Lab Operations

Bio Spectrum

|

September 2025

India's research landscape is undergoing rapid transformation as institutions look toward hybrid and remote working models to enhance flexibility and collaboration. By turning to cloudbased lab systems and AI-powered analytics, R&D organisations can build agile, future-ready environments to help power India's academic and industrial sectors.

Driving Research Continuity in Indian R&D through Remote Lab Operations

Dr Mary Donlan, Executive Director, Product Marketing, Revvity Signals

The COVID-19 pandemic marked a turning point for research and development practices throughout the world. With restricted access to physical laboratories due to nationwide lockdowns, traditional on-site research models were disrupted overnight. In response, R&D organisations were compelled to adopt hybrid and remote research models, combining in-person lab work with digital off-site data analysis.

Ignited by the short-term necessity of COVID-19, digital R&D solutions have now evolved to redefine remote research frameworks and transform how research continuity is maintained. Moving from manual processes largely confined within the four walls of the lab to data-driven research that is independent of location, institutions have learned that the data itself represents the greatest store of value. As a result, reliable, flexible, secure access to lab-generated data is at a premium, and remote and cloud solutions have surged to fill a market gap.

For example, in a survey conducted soon after the start of the pandemic, Deloitte showed that drug companies rated cloud computing as one of the highest priorities of the following 5 years.

In the work-from-anywhere hybrid environment, it is no longer practical for data to be encased within physical lab notebooks or local data systems.

Researchers working from different locations require safe, real-time access, analysis and sharing of protocols and experimental results to maintain momentum in their projects and promote collaboration across departments and institutions.

In this new environment, cloud-based Electronic Lab Notebooks (ELNs) with AI-powered data analytic platforms play a key role. These solutions enable remote data accessibility, enhanced data integrity, and compliance with regulatory standards – crucial factors in both academic research and industrial R&D.

WEITERE GESCHICHTEN VON Bio Spectrum

Bio Spectrum

Bio Spectrum

MAHE teams up with OpenAI to integrate AI to enhance outcomes

Manipal Academy of Higher Education (MAHE), an Institution of Eminence Deemed to be University in Karnataka, has partnered with OpenAI to integrate advanced artificial intelligence (AI) tools across teaching, research, and academic administration.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Jubilant Bhartia Foundation & McGill University to launch CoE in AI education

The Jubilant Bhartia Foundation in collaboration with McGill University (Canada), has signed a Memorandum of Understanding (MoU) to create the Centre of Excellence (CoE) in artificial intelligence (AI) Education and Research.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Heeding Auditory Warning Signs

By 2050, nearly 2.5 billion people are projected to have some degree of hearing loss, and more than 700 million might require hearing rehabilitation. That's according to the World Health Organization (WHO).

time to read

2 mins

April 2026

Bio Spectrum

Bio Spectrum

Botanic Healthcare on-boards Narahari Naidu as Group Chief Financial Officer

Secundarabad-based Botanic Healthcare, a globally leading nutraceutical company, has announced the appointment of Narahari Naidu as its Group Chief Financial Officer (CFO).

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Paras Health ropes in Balkishan Sharma as Group CHRO and Business Transformation Officer

Paras Health has announced the appointment of Balkishan Sharma as Group Chief Human Resources Officer (Group CHRO) and Business Transformation Officer.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Parse Biosciences unveils Evercode Whole Transcriptome V4 with shorter workflow

Parse Biosciences, a Qiagen company, has announced the launch of the new Evercode Whole Transcriptome v4 product line, delivering expanded scalability, higher sensitivity and a simplified workflow for single-cell RNA sequencing. Evercode v4 supports extraordinary scalability of up to five million cells and 384 samples in a single run, enabling researchers

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

UK deploys new bone scanners to help prevent fractures

Tens of thousands of patients at risk of osteoporosis and other bone conditions will get faster access to vital bone scans, as 20 new scanners are rolled out across England.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Cytiva expands Fast Trak process development and validation services facility in India

Cytiva, a Danaher company and a leader in the life sciences industry, has inaugurated an expanded facility for Fast Trak process development (PD) and validation services in Bengaluru.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

ΑΙ TAKES INDIAN PHARMA REINS

The Indian pharmaceutical sector, one of the largest in the world, is undergoing a strategic transformation in the way it operates. As artificial intelligence (AI) gains prominence across the industry, companies are actively adopting Al-driven solutions to enhance efficiency across the entire pharmaceutical ecosystem. Organisations are investing in AI training programmes to keep their workforce future-ready, foster innovation, strengthen supply chains, and transition away from manual record-keeping. In this industry analysis, experts share their perspectives on how AI is shaping the future of the pharma sector.

time to read

10 mins

April 2026

Bio Spectrum

NIH halts arm of clinical trial evaluating potential stroke treatment

The National Institutes of Health (NIH) in the US has stopped an investigational treatment arm of the Comparison of Anti-coagulation and Anti-platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA) study, following a regular review by the Data Safety and Monitoring Board (DSMB).

time to read

1 min

April 2026

Listen

Translate

Share

-
+

Change font size